SCHEMBL328416

SCHEMBL328416

CCOC(=O)N(C)CCN(CC(N)=O)S(=O)(=O)c1cc(F)c(Oc2ccc(F)cc2)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.35
CETP P11597 1/20 0.34
ALDH1A1 P00352 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
LMNA P02545 3/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
MMP1 P03956 1/20 0.33
MMP7 P09237 1/20 0.33
MMP8 P22894 1/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
SLC9A3 P48764 4/20 0.33
TAS2R14 Q9NYV8 1/20 0.32
HTT P42858 1/20 0.32
CACNA1H O95180 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6863608 0.89 MMP1 (0.47) MMP1MMP7MMP8MMP12MMP13
SCHEMBL328408 0.88 PDK2 (0.35) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL6852278 0.87 CACNA1H (0.40) SMN1; SMN2ALDH1A1KDM4ELMNAKMT2A
SCHEMBL328473 0.82 F13A1 (0.41) LMNACACNA1H
SCHEMBL328409 0.81 MMP1 (0.38) SMN1; SMN2ALDH1A1RAB9ALMNAKMT2A
SCHEMBL328403 0.81 MEN1 (0.40) SMN1; SMN2ALDH1A1GAALMNAKMT2A
SCHEMBL328418 0.79 MMP1 (0.45) ALDH1A1LMNAMMP1MMP7MMP8
SCHEMBL6852386 0.79 MMP3 (0.38) KMT2AMEN1MMP1MMP13PTGS2
SCHEMBL6850891 0.79 ALDH1A1 (0.43) SMN1; SMN2ALDH1A1NPC1RAB9ALMNA
SCHEMBL328478 0.79 LMNA (0.35) LMNASLC9A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2428509-A1 Human adam-10 inhibitors Symphony Evolution, Inc. (US) 2012-03-14 EP disclosed
WO-2011011181-A1 PHARMACOLOGICAL CHAPERONES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AMICUS THERAPEUTICS, INC. (US) 2011-01-27 WO disclosed